References
- de Visscher AV, Manni JJ. Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx, pharynx, and oral cavity. Does it make sense? Arch Otolaryngol Head Neck Surg 1994; 120:934–9.
- Digonnet A, Hamoir M, Andry G, Haigentz M, Jr., Takes RP, Silver CE, . Post-therapeutic surveillance strategies in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol Epub 2012 Sep 13.
- Overgaard J, Hansen HS, Specht L, Overgaard M, Grau C, Andersen E, . Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 2003;362:933–40.
- Grau C, Specht LK, Hansen HS, Overgaard M, Overgaard J. [Centralized follow-up of patients treated for head and neck cancer]. Ugeskr Laeger 1997;159:1104–8.
- Kothari P, Trinidade A, Hewitt RJ, Singh A, O’Flynn P. The follow-up of patients with head and neck cancer: An analysis of 1,039 patients. Eur Arch Otorhinolaryngol 2011;268:1191–200.
- Agrawal A, deSilva BW, Buckley BM, Schuller DE. Role of the physician versus the patient in the detection of recurrent disease following treatment for head and neck cancer. Laryngoscope 2004;114:232–5.
- Schwartz DL, Barker J, Jr., Chansky K, Yueh B, Raminfar L, Drago P, . Postradiotherapy surveillance practice for head and neck squamous cell carcinoma – too much for too little?Head Neck 2003;25:990–9.
- Ataman OU, Barrett A, Davidson S, De Haas-Kock D, Dische S, Dubray B, . Audit of effectiveness of routine follow-up clinics after radiotherapy for cancer: A report of the REACT working group of ESTRO. Radiother Oncol 2004;73:237–49.
- Overgaard J, Hansen HS, Jorgensen K, Hjelm HM. Primary radiotherapy of larynx and pharynx carcinoma – an analysis of some factors influencing local control and survival. Int J Radiat Oncol Biol Phys 1986;12:515–21.
- Boysen M, Lovdal O, Tausjo J, Winther F. The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer 1992;28:426–30.
- Lester SE, Wight RG. ‘When will I see you again?‘ Using local recurrence data to develop a regimen for routine surveillance in post-treatment head and neck cancer patients. Clin Otolaryngol 2009;34:546–51.
- Jensen K, Lambertsen K, Grau C. Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: Frequency, intensity and correlation with dose and volume parameters. Radiother Oncol 2007;85:74–82.
- Mortensen HR, Overgaard J, Specht L, Overgaard M, Johansen J, Evensen JF, . Prevalence and peak incidence of acute and late normal tissue morbidity in the DAHANCA 6 & 7 randomised trial with accelerated radiotherapy for head and neck cancer.Radiother Oncol 2012;103:69–75.
- Haas I, Hauser U, Ganzer U. The dilemma of follow-up in head and neck cancer patients. Eur Arch Otorhinolaryngol 2001;258:177–83.
- Bjordal K, Kaasa S. Psychological distress in head and neck cancer patients 7–11 years after curative treatment. Br J Cancer 1995;71:592–7.
- Rennemo E, Zatterstrom U, Boysen M. Impact of second primary tumors on survival in head and neck cancer: An analysis of 2,063 cases. Laryngoscope 2008;118:1350–6.
- Johansen LV, Overgaard J, Hjelm-Hansen M, Gadeberg CC. Primary radiotherapy of T1 squamous cell carcinoma of the larynx: Analysis of 478 patients treated from 1963 to1985. Int J Radiat Oncol Biol Phys1990;18:1307–13.
- Flynn CJ, Khaouam N, Gardner S, Higgins K, Enepekides D, Balogh J, . The value of periodic follow-up in the detection of recurrences after radical treatment in locally advanced head and neck cancer. Clin Oncol (R Coll Radiol) 2010;22:868–73.
- O’Meara WP, Thiringer JK, Johnstone PA. Follow-up of head and neck cancer patients post-radiotherapy. Radiother Oncol 2003;66:323–6.